[HTML][HTML] Chromobacterium spp. mediate their anti-Plasmodium activity through secretion of the histone deacetylase inhibitor romidepsin

RG Saraiva, CR Huitt-Roehl, A Tripathi, YQ Cheng… - Scientific reports, 2018 - nature.com
Abstract The Chromobacterium sp. Panama bacterium has in vivo and in vitro anti-
Plasmodium properties. To assess the nature of the Chromobacterium-produced anti …

[HTML][HTML] The status and prospects of epigenetics in the treatment of lymphoma

J Liu, J Li, H Wu, P Liu - Frontiers in Oncology, 2022 - frontiersin.org
The regulation of gene transcription by epigenetic modifications is closely related to many
important life processes and is a hot research topic in the post-genomic era. Since the …

Targeting epigenetic regulation for cancer therapy using small molecule inhibitors

A Kumar, L Emdad, PB Fisher, SK Das - Advances in Cancer Research, 2023 - Elsevier
Cancer cells display pervasive changes in DNA methylation, disrupted patterns of histone
posttranslational modification, chromatin composition or organization and regulatory …

[HTML][HTML] Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency

SE Hopcraft, SG Pattenden, LI James, S Frye… - PLoS …, 2018 - journals.plos.org
Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiologic agent of three human
malignancies, the endothelial cell cancer Kaposi's sarcoma, and two B cell cancers, Primary …

Discovery and Development of Cyclic Peptide Proteasome Stimulators

S Nelson, TJ Harris, CS Muli, ME Maresh… - …, 2024 - Wiley Online Library
The proteasome degrades proteins, which is essential for cellular homeostasis. Ubiquitin
independent proteolysis degrades highly disordered and misfolded proteins. A decline of …

Anticancer potential of naturally occurring immunoepigenetic modulators: A promising avenue?

M Schnekenburger, M Dicato, MF Diederich - Cancer, 2019 - Wiley Online Library
The immune system represents the major primary defense line against carcinogenesis and
acts by identifying and eradicating nascent transformed cells. A growing body of evidence is …

[HTML][HTML] Optimization of resveratrol used as a scaffold to design histone deacetylase (HDAC-1 and HDAC-2) inhibitors

BS Urias, AR Pavan, GR Albuquerque, IM Prokopczyk… - Pharmaceuticals, 2022 - mdpi.com
Histone deacetylases (HDAC) are epigenetic enzymes responsible for repressing gene
expression through the deacetylation of histone lysine residues. Therefore, inhibition of …

Structure-based design of a selective class I histone deacetylase (HDAC) near-infrared (NIR) probe for epigenetic regulation detection in triple-negative breast cancer …

K Zhang, Z Liu, Y Yao, Y Qiu, F Li, D Chen… - Journal of Medicinal …, 2021 - ACS Publications
Abnormally high levels of class I histone deacetylases (HDACs) are associated with triple-
negative breast cancer (TNBC) proliferation, malignant transformation, and poor prognosis …

Discovery of a Dual‐Target Inhibitor of CDK7 and HDAC1 That Induces Apoptosis and Inhibits Migration in Colorectal Cancer

Y Chen, S Zhang, Z Li, B Yin, Y Liu, L Zhang - ChemMedChem, 2023 - Wiley Online Library
Aberrant expression or dysfunction of cyclin‐dependent kinase 7 (CDK7) and histone
deacetylase 1 (HDAC1) are associated with the occurrence and progression of various …

Antibody drug conjugates beyond cytotoxic payloads.

AD Hobson - Progress in Medicinal Chemistry, 2023 - europepmc.org
For many years, antibody drug conjugates (ADC) have teased with the promise of targeted
payload delivery to diseased cells, embracing the targeting of the antibody to which a …